The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Interesting post and you certainly hold many more than me.
Regarding JAs holding, I don’t think you can check other than by viewing the shareholder’s register. What i would say is that having met him on two occasions and had conversations with him I do not doubt his intent to get Cameroon done. It is a long way off (June) but I suggest that you come along to the next AGM.
Some look to make a short term profit and good for them if they want to; but those of us who have done the research and are long term holders will likely make the bigger gain. For example, I forecast 0.1p plus just on confirmation of licence renewal. Having said that, as ever DYOR!
How many more times do we have to tell people that the directors are not paid but take warrants. They get paid if the company is successful. It is tedious when people do not do any research before posting.
Well I hope so :-)
Waiting for the due diligence on the acquisition to be completed. The company said 2-8 months, hopefully 2 not 8!
Well worth watching as he busts a lot of the myths. The problem today though is that anyone with an alternative view struggles to be heard, or, in the current parlance, is cancelled.
Courtesy of a poster in a group I belong to here is a copy of a presentation being given in Athens today by the Greek subsidiary of ROCK. It looks like Germanium could be a catalyst to success.
https://acrobat.adobe.com/id/urn:aaid:sc:EU:5096c9f1-c4b3-4f4c-9ea0-3d966c3835bb